Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.

MLA

Costales, Anthony B., et al. “Laparoscopic Predictability of Minimally Invasive Interval Debulking in Advanced Ovarian Cancer: The MIID-SOC Trial.” Gynecologic Oncology, vol. 185, June 2024, pp. 143–47. EBSCOhost, https://doi.org/10.1016/j.ygyno.2024.02.019.

APA

Costales, A. B., Crane, E. K., Chambers, L., Yao, M., Chau, D., Naumann, W. R., Debernardo, R., Ricci, S., Rose, P. G., & Michener, C. M. (2024). Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial. Gynecologic Oncology, 185, 143–147. https://doi.org/10.1016/j.ygyno.2024.02.019

Chicago

Costales, Anthony B, Erin K Crane, Laura Chambers, Meng Yao, Danielle Chau, Wendel R Naumann, Robert Debernardo, Stephanie Ricci, Peter G Rose, and Chad M Michener. 2024. “Laparoscopic Predictability of Minimally Invasive Interval Debulking in Advanced Ovarian Cancer: The MIID-SOC Trial.” Gynecologic Oncology 185 (June): 143–47. doi:10.1016/j.ygyno.2024.02.019.